Research Article

Related GMR Articles

04/28/2016
Esophageal cancer; Genetic variant; Polymorphism; Tumor necrosis factor-alpha
H. Zhao; H.W. Zhang; T. Zhang; X.M. Gu; H. Zhao; H.W. Zhang; T. Zhang; X.M. Gu; H. Zhao; H.W. Zhang; T. Zhang; X.M. Gu; H. Zhao; H.W. Zhang; T. Zhang; X.M. Gu; H. Zhao; H.W. Zhang; T. Zhang; X.M. Gu
06/20/2016
Basigin gene; Esophageal cancer; miR-483-5p; Polymorphism

The aim of this study was to investigate the association between a functional variant of the basigin (BSG) gene, caused by a polymorphism (rs11473) at the miR-483-5p binding site, and the risk of esophageal squamous cell carcinoma (ESCC) in the Chinese population. The rs11473 polymorphism was genotyped in 624 esophageal cancer patients and 636 cancer-free age- and gender-matched ... more

H.Y. Li; Y.C. Liu; Y.H. Bai; M. Sun; L. Wang; X.B. Zhang; B. Cai; H.Y. Li; Y.C. Liu; Y.H. Bai; M. Sun; L. Wang; X.B. Zhang; B. Cai
03/31/2016
ERCC1; ERCC2; Pancreatic cancer; Polymorphism

We conducted a study to investigate the association between ERCC1 (rs3212986) and ERCC2 (rs13181) gene polymorphisms and the risk of pancreatic cancer in a Chinese population. A total of 217 pancreatic cancer patients and 244 control subjects were recruited from the Nuclear Industry 215 Hospital of Shaanxi Province between February 2013 and December 2014. Genomic DNA was ... more

M.G. He; K. Zheng; D. Tan; Z.X. Wang; M.G. He; K. Zheng; D. Tan; Z.X. Wang; M.G. He; K. Zheng; D. Tan; Z.X. Wang
04/26/2016
ERCC1; ERCC2; Gastric cancer; Polymorphism; Treatment outcome

We conducted a prospective study to investigate whether ERCC1 rs11615 and rs3212986 and ERCC2 rs13181 and rs1799793 gene polymorphisms could serve as potential biomarkers for the prognosis of gastric cancer. Between January 2010 and December 2012, 246 patients with pathologically proven gastric cancer who were receiving platinum-based chemotherapy were recruited from the ... more

D.L. Zheng; G.D. Tang; Y.N. Chen; T. Zhang; M.B. Qin; D.L. Zheng; G.D. Tang; Y.N. Chen; T. Zhang; M.B. Qin; D.L. Zheng; G.D. Tang; Y.N. Chen; T. Zhang; M.B. Qin
05/23/2016
Bladder cancer; Chemotherapy; ERCC1; Polymorphism

This study aims to investigate the association between ERCC1 codon C118T polymorphism and the response rate of platinum-based chemotherapy in patients with late-stage bladder cancer. A total of 41 eligible patients histologically confirmed as having stage IV muscle-invasive transitional cell carcinoma of the bladder were treated with platinum-based chemotherapy for 2-6 cycles. ... more

Z.C. Xu; H.Z. Cai; X. Li; W.Z. Xu; T. Xu; B. Yu; Q. Zou; L. Xu; Z.C. Xu; H.Z. Cai; X. Li; W.Z. Xu; T. Xu; B. Yu; Q. Zou; L. Xu
06/21/2016
Apoptosis; Bcl-2; Borax; HepG2 cells; Mitochondrial membrane potential; p53

Borax, a boron compound and a salt of boric acid, is known to inhibit the growth of tumor cells. HepG2 cells have been shown to be clearly susceptible to the anti-proliferative effects of borax. However, the specific mechanisms regulating this effect are poorly understood. This study aimed to investigate the pathways underlying the growth inhibition induced by borax in HepG2 cells. The ... more

Y. Wei; F.J. Yuan; W.B. Zhou; L. Wu; L. Chen; J.J. Wang; Y.S. Zhang; Y. Wei; F.J. Yuan; W.B. Zhou; L. Wu; L. Chen; J.J. Wang; Y.S. Zhang
05/25/2016
CYP1A1; Estrogen receptor β; GSTM1; GSTT1; p53; Progesterone receptor

In healthy women, intra- and extracellular controls prevent the attachment and proliferation of ectopic endometrial cells. During endometriosis, abnormalities in these control mechanisms permit the survival of endometrial cells, their subsequent attachment to the peritoneal cavity, and disease progression. These abnormal cells cause invasion of tissues and induce an inflammatory response ... more

K.S.F. Silva; K.K.V.O. Moura; K.S.F. Silva; K.K.V.O. Moura
06/03/2016
CDK4; Esophageal cancer; MiR-124; Radiotherapy

Radiotherapy is one of the most important treatments for esophageal cancer, but radioresistance remains a major challenge. Previous studies have shown that microRNAs (miRNAs or miRs) are involved in human cancers. miR-124 has been widely reported in various cancers and it is intimately involved in proliferation, cell cycle regulation, apoptosis, migration, and invasion of cancer cells. ... more

Y.H. Zhang; Q.Q. Wang; H. Li; T. Ye; F. Gao; Y.C. Liu; Y.H. Zhang; Q.Q. Wang; H. Li; T. Ye; F. Gao; Y.C. Liu
09/22/2015
Chemotherapy; ERCC1; ERCC2; Osteosarcoma; Overall survival; Single nucleotide polymorphism

We assessed the role of single nucleotide polymorphisms (SNPs) in ERCC1 and ERCC2 genes in the clinical outcomes for osteosarcoma patients receiving cisplatin-based treatment. A perspective study was conducted on 260 patients with osteosarcoma during 2010 and 2011. A polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay was used to assess ... more

Q. Zhang; L.Y. Lv; B.J. Li; J. Zhang; F. Wei
08/21/2015
Clinical outcome; ERCC1; ERCC2; Osteosarcoma; Polymorphism

We aimed to evaluate the influence of four SNPs in ERCC1 and ERCC2 on the response to cisplatin-based treatment and on clinical outcome in patients with osteosarcoma. We identified 186 patients with osteosarcoma diagnosed between April 2009 and April 2011 who were eligible for inclusion in our study. Genotyping of ERCC1 rs11615, rs3212986, and rs2298881; and ... more

Z.H. Cao; H.P. Yin; N. Jiang; B. Yu

Pages